Federal Register / Vol. 86, No. 17 / Thursday, January 28, 2021 / Notices 7393 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–21–20PR] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled Improving 

Safety of Human-Robot Interaction to 

the Office of Management and Budget 

(OMB) for review and approval. CDC 

previously published a ‘‘Proposed Data 

Collection Submitted for Public 

Comment and Recommendations’’ 

notice on August 26, 2020 to obtain 

comments from the public and affected 

agencies. CDC did not receive comments 

related to the previous notice. This 

notice serves to allow an additional 30 

days for public and affected agency 

comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Improving Safety of Human-Robot 

Interaction—New—National Institute 

for Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

The mission of the National Institute 

for Occupational Safety and Health 

(NIOSH) is to promote safety and health 

at work for all people through research 

and prevention. NIOSH has initiated a 

study among manufacturing workers to 

improve safety of workers that work in 

close proximity with robots. Study 

results will be used to improve safety 

standards and lead to better design 

guidelines for industrial robots. 

Rapid growth of advanced 

collaborative and mobile robots 

warrants investigation on safe humanrobot interaction for their potential 

injurious energy transmission from a 

robot to a worker. Traditional safety 

measures for industrial robots, such as 

protective barriers, are no longer valid 

for the emerging collaborative and 

mobile robots. Physical contacts 

between human workers and robots are 

inevitable and even desired when they 

share a common workspace or work 

directly with each other under 

collaborative operations. Therefore, 

NIOSH is proposing a study to evaluate 

the effects of different characteristics of 

robots on human behaviors, perceived 

safety, workload, and trust. 

The study will take advantage of 

virtual reality technology to simulate 

human-robot interaction during data 

collection sessions. Participants will 

conduct two related experiments that 

will involve performing simulated 

warehouse tasks (e.g., loading/ 

unloading boxes from shelves) in a 

virtual reality laboratory. Participants 

will interact with a mobile robot in the 

first experiment and a collaborative 

robot arm in the second. They will wear 

glasses that will allow them to see 

virtual 3D images of the robots and 

other objects in the environment. During 

each experiment task, we will use 

motion capture technology to track the 

movement and location of the 

participants and the virtual robots. This 

will allow us to track movement speed 

and separation distance from the virtual 

robots. After each experiment task, we 

will administer three questionnaires to 

the participants that will ask them about 

their perceived safety, mental workload, 

and trust in the robots. We will analyze 

how these measures change based on 

the virtual robot’s operating speed, size, 

and movement trajectory. 

Data collections will occur at the 

NIOSH facility in Morgantown, West 

Virginia. The target study population 

will be workers who currently work or 

had worked in the manufacturing 

industry, with varying job experiences. 

The burden table below accounts for 

111 respondents over a three-year data 

collection period. Respondents will 

complete all forms only once, besides 

the Virtual Reality Sickness 

Questionnaire, which will be 

administered at the beginning and end 

of the data collection, and the three 

questionnaires (NASA Task Load Index, 

Perceived Safety Questionnaire, and 

Robot Trust Questionnaire), which will 

be administered after each of the 63 

combined experiment trials for 

Experiments 1 and 2. The total 

estimated burden hours is 216. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Manufacturing Workers .................... Simulator Sickness Susceptibility Questionnaire .......... 37 1 1/60 

Consent Form ............................................................... 37 1 10/60 

Participant Data Collection Form .................................. 37 1 1/60 

Virtual Reality Sickness Questionnaire ......................... 37 2 1/60 

Robot Experience Questionnaire .................................. 37 1 6/60 

7394 Federal Register / Vol. 86, No. 17 / Thursday, January 28, 2021 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Actual Experiment 1—Mobile Robot ............................. 37 1 70/60 

Actual Experiment 2—Collaborative Robot .................. 37 1 70/60 

NASA Task Load Index ................................................ 37 63 1/60 

Perceived Safety Questionnaire ................................... 37 63 1/60 

Robot Trust Questionnaire ............................................ 37 63 1/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–01692 Filed 1–27–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–21–20QS] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘Proposed Data 

Collection Multi-Site Clinical 

Assessment of Myalgic 

Encephalomyelitis/Chronic Fatigue 

Syndrome (MCAM)’’ to the Office of 

Management and Budget (OMB) for 

review and approval. CDC previously 

published a 60-day notice titled 

‘‘Proposed Data Collection Submitted 

for Public Comment and 

Recommendations’’ on August 3, 2020 

to obtain comments from the public and 

affected agencies. CDC received three 

comments related to the previous 

notice. This notice serves to allow an 

additional 30 days for public and 

affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Multi-Site Clinical Assessment of 

Myalgic Encephalomyelitis/Chronic 

Fatigue Syndrome (MCAM)—Existing 

collection in use without an OMB 

Control Number—National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

This Multi-site Clinical Assessment of 

Myalgic Encephalomyelitis/Chronic 

Fatigue Syndrome (MCAM) study uses a 

standardized approach for data 

collection to examine the heterogeneity 

of patients with Myalgic 

Encephalomyelitis/Chronic Fatigue 

Syndrome (ME/CFS) using a clinical 

epidemiologic longitudinal study with a 

retrospective and prospective rolling 

cohort design. The study also aims to 

address the issue of ME/CFS case 

definition and improve measures of 

illness domains by using evidencebased data from multiple clinical 

practices in the United States. Healthy 

adults and those with illnesses that 

share some features with ME/CFS were 

enrolled in comparison groups. 

Children and adolescents with ME/CFS 

and healthy participants were also 

enrolled. 

The MCAM study has been conducted 

in multiple stages following multiple 

study protocols. The time burden 

estimates are based on the 2012–2019 

data collection, which is the most recent 

stage of data collection completed. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of 

respondents Form name Number of participants 

Number of 

responses per 

participant 

Average 

burden per 

response 

(in hrs.) 

Adult ........................................ CDC Symptom Inventory (CDC–SI)/Form A .......................... 45 1 12/60 

Adult ........................................ CDC Symptom Inventory (CDC–SI)/Form B .......................... 20 1 10/60 

Adult ........................................ CDC Symptom Inventory (CDC–SI) ....................................... 20 1 8/60 

Adult ........................................ Short Form CDC–SI/Checklist ............................................... 85 1 10/60 

Adult ........................................ Medical Outcomes Study Short Form 36 ............................... 85 1 7/60